BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23809258)

  • 1. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
    Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
    Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
    Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
    Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells.
    Candelaria NR; Addanki S; Zheng J; Nguyen-Vu T; Karaboga H; Dey P; Gabbi C; Vedin LL; Liu K; Wu W; Jonsson PK; Lin JZ; Su F; Bollu LR; Hodges SE; McElhany AL; Issazadeh MA; Fisher WE; Ittmann MM; Steffensen KR; Gustafsson JÅ; Lin CY
    PLoS One; 2014; 9(9):e106289. PubMed ID: 25184494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of LXR-β in human gastric cancer tissue and the effect of GW3965 on the proliferation of gastric cancer cell line SGC-7901].
    Wang R; Li R; Wen Q; Peng K; Tan X; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):127-33. PubMed ID: 26932209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
    Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
    Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells.
    Premaratne A; Ho C; Basu S; Khan AF; Bawa-Khalfe T; Lin CY
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
    Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
    J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lxr regulates lipid metabolic and visual perception pathways during zebrafish development.
    Pinto CL; Kalasekar SM; McCollum CW; Riu A; Jonsson P; Lopez J; Swindell EC; Bouhlatouf A; Balaguer P; Bondesson M; Gustafsson JÅ
    Mol Cell Endocrinol; 2016 Jan; 419():29-43. PubMed ID: 26427652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism.
    Nader N; Ng SS; Wang Y; Abel BS; Chrousos GP; Kino T
    PLoS One; 2012; 7(3):e26751. PubMed ID: 22457708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased metastasis with loss of E2F2 in Myc-driven tumors.
    Yuwanita I; Barnes D; Monterey MD; O'Reilly S; Andrechek ER
    Oncotarget; 2015 Nov; 6(35):38210-24. PubMed ID: 26474282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of Hedgehog signaling by liver X receptors.
    Kim WK; Meliton V; Park KW; Hong C; Tontonoz P; Niewiadomski P; Waschek JA; Tetradis S; Parhami F
    Mol Endocrinol; 2009 Oct; 23(10):1532-43. PubMed ID: 19608643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity.
    Karaboga H; Huang W; Srivastava S; Widmann S; Addanki S; Gamage KT; Mazhar Z; Ebalunode JO; Briggs JM; Gustafsson JÅ; Filgueira CS; Gilbertson SR; Lin CY
    ACS Chem Biol; 2020 Nov; 15(11):2916-2928. PubMed ID: 33074669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver X receptors induce antiproliferative effects in basal-like breast cancer.
    Haugen MH; von der Lippe Gythfeldt H; Egeland EV; Svartdal Normann L; Pandya AD; Vedin LL; Juell S; Tenstad E; Øy GF; Kristian A; Marangoni E; Sørlie T; Steffensen K; Maelandsmo GM; Engebraaten O
    Mol Oncol; 2023 Oct; 17(10):2041-2055. PubMed ID: 37341140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZMIZ1 enhances ERα-dependent expression of E2F2 in breast cancer.
    Zhao W; Rose SF; Blake R; Godicelj A; Cullen AE; Stenning J; Beevors L; Gehrung M; Kumar S; Kishore K; Sawle A; Eldridge M; Giorgi FM; Bridge KS; Markowetz F; Holding AN
    J Mol Endocrinol; 2024 Jul; 73(1):. PubMed ID: 38564418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor LXR is a glucose sensor.
    Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
    Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. System analysis of cross-talk between nuclear receptors reveals an opposite regulation of the cell cycle by LXR and FXR in human HepaRG liver cells.
    Wigger L; Casals-Casas C; Baruchet M; Trang KB; Pradervand S; Naldi A; Desvergne B
    PLoS One; 2019; 14(8):e0220894. PubMed ID: 31437187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target.
    Hong C; Walczak R; Dhamko H; Bradley MN; Marathe C; Boyadjian R; Salazar JV; Tontonoz P
    J Lipid Res; 2011 Mar; 52(3):531-9. PubMed ID: 21187453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LXR as a novel antithrombotic target.
    Spyridon M; Moraes LA; Jones CI; Sage T; Sasikumar P; Bucci G; Gibbins JM
    Blood; 2011 May; 117(21):5751-61. PubMed ID: 21411760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.